Insulin action in morbid obesity: A focus on muscle and adipose tissue

Hormones

Volumn 12, Issue 2, 2013, Pages 201-213

  Mitrou, Panayota ^a   Raptis, Sotirios A ^a,b   Dimitriadis, George ^b  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Adipose tissue; Cytokines; Glucose metabolism; Insulin action; Insulin resistance; Lipid metabolism; Morbid obesity; Muscle

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CYTOKINE; FATTY ACID; GLUCOSE; GLUCOSE TRANSPORTER 4; HORMONE SENSITIVE LIPASE; INSULIN; INTERLEUKIN 6; LEPTIN; LIPOPROTEIN LIPASE; RECOMBINANT LEPTIN; RESISTIN; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; BARIATRIC SURGERY; BLOOD FLOW VELOCITY; DIABETES MELLITUS; DISEASE ASSOCIATION; EXERCISE; FAT INTAKE; FAT MASS; GLUCONEOGENESIS; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; HORMONE ACTION; HUMAN; HYPERINSULINEMIA; HYPERLIPIDEMIA; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; LIPOTOXICITY; LOW CALORY DIET; MORBID OBESITY; MUSCLE BLOOD FLOW; MUSCLE TISSUE; NONHUMAN; OBESITY; REVIEW; SIGNAL TRANSDUCTION; WEIGHT REDUCTION;

ADIPOKINES; ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; CYTOKINES; GLUCONEOGENESIS; GLUCOSE; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LIPID METABOLISM; LIVER; MODELS, BIOLOGICAL; MUSCLE, SKELETAL; OBESITY, MORBID; PREDIABETIC STATE;

EID: 84880709690     PISSN: 11093099     EISSN: None     Source Type: Journal    
DOI: 10.14310/horm.2002.1404     Document Type: Review

References (79)

1. Maratos-Flyer E, Flyer JS 2005 Obesity. In: Kahn CR, Weir GC, King GL, Jacobson AM, Moses AC, Smith RL (eds) Joslin's Diabetes Mellitus, Lippincott Williams and Wilkins, Philadelphia, Baltimore, New York, London, Buenos Aires, Hong Kong, Sydney, Tokyo; pp, 533-546.
2. Dimitriadis G, Mitrou P, Lambadiari V, Maratou E, Raptis SA, 2011 Insulin effects in muscle and adipose tissue. Diabetes Res Clin Pract 93: Suppl 1: 52-59.
3. Mitrou P, Boutati E, Lambadiari V, et al, 2009 Rates of glucose uptake in adipose tissue and muscle in vivo after a mixed meal in women with morbid obesity. J Clin Endocrinol Metab 94: 2958-2961.
4. Virtanen K, Lozzo P, Hallsten K, et al, 2005 Increased fat mass compensates for insulin resistance in abdominal obesity and type 2 diabetes. Diabetes 54: 2720-2726.
5. Frayn K, 2002 Adipose tissue as a buffer for daily lipid flux. Diabetologia 45: 1201-1210.
6. Coppack S, Evans R, Fisher R, et al, 1992 Adipose tissue metabolism in obesity: lipase action in vivo before and after a mixed meal. Metabolism 41: 264-272.
7. Jocken JW, Langin D, Smit E, et al, 2007 Adipose triglyceride (ATGL) and hormone-sensitive lipase (HSL) protein expression is decreased in the obese insulin resistant state. J Clin Endocrin Metab 92: 2292-2299.
8. Langin D, Dicker A, Tavernier G, et al, 2005 Adipocyte lipases and defect of lipolysis in human obesity. Diabetes 54: 3190-3197.
9. Wellen K, Hotamisligil G, 2005 Inflammation, stress, and diabetes. J Clin Invest 115: 1111-1119.
10. Rabe K, Lehrke M, Parhofer KG, Broedl UC, 2008. Adipokines and insulin resistance. Mol Med 14: 741-751.
11. Polonsky KS, 2000 Dynamics of insulin secretion in obesity and diabetes. Int J Obes 24: Suppl 2: 29-31.
12. Camastra S, Manco M, Mari A, et al, 2005 Beta-cell function in morbidly obese subjects during free living. Long-term effects of weight loss. Diabetes 54: 2382-2389.
13. Grill V, Qvigstad E 2000 Fatty acids and insulin secretion. Br J Nutr 83: Suppl 1: 79-84.
14. Woods SC, Porte D Jr, Bobbioni E, et al, 1985 Insulin: its relationship to the central nervous system and to the control of food intake and body weight. Am J Clin Nutr 42: Suppl 5: 1063-1071.
15. Schwartz MW, Woods SC, Seeley RJ, Barsh GS, Baskin DG, Leibel RL, 2003 Is the energy homeostasis system inherently biased toward weight gain? Diabetes 52: 232-238.
16. Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G, 1997 Insulin resistance and hypersecretion in obesity. J Clin Invest 100: 1166-1173.
17. Polyzogopoulou EV, Kalfarentzos F, Vagenakis AG, Alexandrides TK, 2003 Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery. Diabetes 52: 1098-1103.
18. Camastra S, Gastaldelli A, Mari A, et al, 2011 Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes. Diabetologia 54: 2093-2102.
19. Lin E, Liang Z, Frediani J, et al, 2010 Improvement in β-cell function in patients with normal and hyperglycemia following Roux-en-Y gastric bypass surgery. Am J Physiol Endocrinol Metab 299: E706-E712.
20. Prager R, Wallace P, Olefsky J, 1986 In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects. J Clin Invest 78: 472-481.
21. Prager R, Wallace P, Olefsky J 1987 Direct and indirect effects of insulin to inhibit hepatic glucose output in obese subjects. Diabetes 36: 607-611.
22. Basu R, Chandramouli V, Dicke B, Landau B, Rizza R, 2005 Obesity and type 2 diabetes impair insulin-induced suppression of glycogenolysis as well as gluconeogenesis. Diabetes 54: 1942-1948.
23. Chevalier S, Burgess S, Malloy C, Gougeon R, Marliss E, Morais J, 2006 The greater contribution of gluconeogenesis to glucose production in obesity is related to increased whole-body protein catabolism. Diabetes 55: 675-681.
24. Dimitriadis G, Newsholme E 2004 Integration of some biochemical and physiologic effects of insulin that may play a role in the control of blood glucose concentration. In: LeRoith D, Taylor S, Olefsky J (eds). Diabetes Mellitus, a fundamental and clinical text, Lippincott Williams and Wilkins: Philadelphia, Baltimore, New York, London, Buenos Aires, Hong Kong, Sydney, Tokyo; pp, 183-197.
25. Coppack S, Fisher R, Humphreys S, Clark M, Pointon J, Frayn K, 1996 Carbohydrate metabolism in insulin resistance: glucose uptake and lactate production by adipose tissue and forearm tissues in vivo before and after a mixed meal. Clin Sci 90: 409-415.
26. Bjorntorp P, Berchtold P, Holm J, Larsson B, 1971 The glucose uptake of human adipose tissue in obesity. Eur J Clin Invest 1: 480-485.
27. Baron A, Laakso M, Brechtel G, Hoit B, Watt C, Edelman S, 1990 Reduced postprandial skeletal muscle blood flow contributes to glucose intolerance in human obesity. J Clin Endocrinol Metab 70: 1525-1533.
28. Dimitriadis G, Lambadiari V, Mitrou P, et al, 2007 Impaired postprandial blood flow in adipose tissue may be an early marker of insulin resistance in type 2 diabetes. Diabetes Care 30: 3128-3130.
29. Friedman J, Lynis Dohm G, Leggett-Frazier N, et al, 1992 Restoration of Insulin Responsiveness in Skeletal Muscle of Morbidly Obese Patients after Weight Loss. Effect on Muscle Glucose Transport and Glucose Transporter GLUT4. J Clin Invest 89: 701-705.
30. Virtanen K, Lonnroth P, Parkkola R, et al, 2002 Glucose uptake and perfusion in subcutaneous and visceral adipose tissue during insulin stimulation in nonobese and obese humans. J Clin Endocrinol Metab 87: 3902-3910.
31. Laine, H, Yki-Järvinen H, Kirvelä O, et al, 1998 Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity. J Clin Invest 101: 1156-1162.
32. Bickerton A, Roberts R, Fielding B, et al, 2007 Preferential uptake of dietary fatty acids in adipose tissue and muscle in the postprandial period. Diabetes 56: 168-176.
33. Mitrou P, Boutati E, Lambadiari V, et al, 2010 Rates of lipid fluxes in the adipose tissue in vivo after a mixed meal in women with morbid obesity. Int J Obes (Lond) 34: 770-774.
34. Reeds D, Stuart C, Perez O, Klein S, 2006 Adipose tissue, hepatic and skeletal muscle insulin sensitivity in extremely obese subjects with acanthosis nigricans. Metabolism 55: 1658-1663.
35. Riemens S, Sluiter W, Dullaart R, 2000 Enhanced escape of non-esterified fatty acids from tissue uptake: its role in impaired insulin-induced lowering of total rate of appearance in obesity and type II diabetes mellitus. Diabetologia 43: 416-426.
36. Gray R, Tanner C, Pories W, MacDonald K, Houmard J, 2003 Effect of weight loss on muscle lipid content in morbidly obese subjects Am J Physiol Endocrinol Metab 284: E726-E732.
37. Yu C, Chen Y, Cline G, et al, 2002 Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277: 50230-50236.
38. Houmard J, Tanner C, Yu C, et al, 2002 Effect of eight loss on insulin sensitivity and intramuscular long-chain fatty Acyl-CoAs in morbidly obese subjects. Diabetes 51: 2959-2963.
39. Greco A, Mingrone G, Giancaterini A, et al, 2002 Insulin resistance in morbid obesity. Reversal with intramyocellular fat depletion. Diabetes 251: 144-151.
40. Mingrone G, Rosa G, Di Rocco P, et al, 2002 Skeletal muscle triglycerides lowering is associated with net improvement of insulin sensitivity, TNF-a reduction and GLUT4 expression enhancement. Int J Obes 26: 1165-1172.
41. Verdelho Machado M, Ferreira D, Castro R, et al, 2012 Liver and muscle in morbid obesity: the interplay of fatty liver and insulin resistance PLoS ONE 7: e31738.
42. Fain J, Madan A, Hiler M, Cheema P, Bahouth S, 2004 Comparison of the release of adipokines by adipose tissue, adipose tissue matrix and adipocytes from visceral and subcutaneous abdominal adipose tissue of obese humans. Endocrinology 145: 2273-2282.
43. Fain J, 2006 Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to nonfat cells. Vitam Horm 74: 443-477.
44. Fischer-Posovsky P, Wabitsch M, Hochberg Z, 2007 Endocrinology of adipose tissue - an update. Horm Metab Res 39:314-321.
45. Klover PJ, Zimmers TA, Koniaris LG, Mooney RA, 2003 Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes 52: 2784-2789.
46. Senn JJ, Klover PJ, Nowak IA, Mooney RA, 2002 Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 51: 3391-3399.
47. Rotter V, Nagaev I, Smith U, 2003 Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumour necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 278: 45777-45784.
48. Carey AL, Steinberg GR, Macaulay SL, et al, 2006 Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes 55: 2688-2697.
49. Al-Khalili L, Bouzakri K, Glund S, Lonnqvist F, Koistinen HA, Krook A, 2006 Signalling specificity of interleu-kin-6 action on glucose and lipid metabolism in skeletal muscle. Mol Endocrinol 20: 3364-3375.
50. Pedersen BK, 2006 The anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control. Essays Biochem 42: 105-117.
51. Chevrel G, Granet C, Miossec P, 2005 Contribution of tumour necrosis factor alpha and interleukin (IL) 1beta to IL6 production, NF-kappa B nuclear translocation, and class 1 MHC expression in muscle cells: in vitro regulation with specific cytokine inhibitors. Ann Rheum Dis 64: 1257-1262.
52. Mitrou P, Lambadiari V, Maratou E, et al, 2011 Skeletal muscle insulin resistance in morbid obesity: the role of intereukin-6 and leptin. Exp Clin Endocrinol Diabetes 119: 484-489.
53. Bruun J, Helge J, Richelsen B, Stallknecht B, 2006 Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects. Am J Physiol Endocrinol Metab 290: E961-E967.
54. Carey AL, Bruce CR, Sacchetti M, et al, 2004 Interleukin-6 and tumor necrosis factor-alpha are not increased in patients with type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness. Diabetologia 47: 1029-1037.
55. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G, 2001 Adipose tissue tumour necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol 280: E745-E751.
56. Franckhauser S, Elias I, Rotter Sopasakis V, et al, 2008 Overexpression of IL-6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice. Diabetologia 51: 1306-1316.
57. Zelissen P, Stenlof K, Lean M, et al, 2005 Effect of three treatment schedules of recombinant methionyl human leptin on body weight in obese adults: a randomized, placebo-controlled trial. Diabetes Obes Metab 7: 755-761.
58. Dyck DJ, 2009 Adipokines as regulators of muscle metabolism and insulin sensitivity. Appl Physiol Nutr Metab 34: 396-402.
59. Dyck DJ, Heigenhauser GJF, Bruce CR, 2006 The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity. Acta Physiologica 186: 5-16.
60. Mohamed-Ali V, Goodrick SJ, Rawesh A, et al, 1997 Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo. J Clin Endocrinol Metab 8: 4196-4200.
61. Hivert MF, Sullivan L, Fox C, et al, 2008 Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance. J Clin Endocrinol Metab 93: 3165-3172.
62. Ofei F, Hurel S, Newkirk J, Sopwith M, Taylor R, 1996 Effects of an engineered human anti-TNF-α antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes 45: 881-885.
63. Paquot N, Castillo M, Lefebre P, Scheen A, 2000 No increased insulin sensitivity after a single intravenous administration of a recombinant human tumor necrosis factor receptor: Fc fusion protein in obese insulin-resistant patients. J Clin Endocrinol Metab 85: 1316-1319.
64. Bullo M, Garcia-Lorda P, Peinado-Onsurbe J, et al, 2002 TNFa expression of subcutaneous adipose tissue in obese and morbid obese females: relationship to adipocyte LPL activity and leptin synthesis. Int J Obesity 26: 652-658.
65. Haseeb A, Iliyas M, Chakrabarti S, et al, 2009 Single-nucleotide polymorphisms in peroxisome proliferators activated receptor gamma and their association with plasma levels of resistin and the metabolic syndrome in a South Indian population. J Biosci 34: 405-414.
66. Asano H, Izawa H, Nagata K, et al, 2010 Plasma resistin concentration determined by common variants in the resistin gene and associated with metabolic traits in an aged Japanese population. Diabetologia 53: 234-246.
67. Beckers S, Peeters A, Freitas F, et al, 2008 Analysis of genetic variations in the resistin gene shows no associations in the resistin gene shows no associations with obesity in women. Obesity 16: 905-907.
68. Lee J, Chan J, Yiannakouris N, et al, 2003 Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab 88: 4848-4856.
69. Curat C, Wegner V, Sengenes C, et al, 2006 Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 49: 744-747.
70. Savage D, Sewter C, Klenk E, et al, 2001 Resistin/ Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes 50: 2199-2202.
71. Motoshima H, Wu X, Sinha M, et al, 2000 Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. J Clin Endocrinol Metab 87: 5662-5667.
72. Sabin M, Holly J, Shield J, et al, 2006 Mature subcutaneous and visceral adipocytes concentrations of adiponectin are highly correlated in prepubertal children and inversely related to body mass index standart deviation score. J Clin Endocrinol Metab 91: 332-335.
73. Bruun JM, Lihn AS, Verdich C, et al, 2003 Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab 285: E527-E533.
74. Hu E, Liang P, Spiegelman BM, 1996 Adipo-q is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271: 10697-10703.
75. Arita Y, Kihara S, Ouchi N, et al, 1999 Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257: 79-83.
76. Hotta K, Funahashi T, Arita Y, et al, 2000 Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arter Thromb Vasc Biol 20: 1595-1599.
77. Statnick MA, Beavers LS, Conner LJ, et al, 2000 Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes. Int J Exp Diabetes Res 1:81-88.
78. Weyer C, Funahashi T, Tanaka S, et al 2001 Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86: 1930-1935.
79. Kim J-Y, Wall E, Laplante M, et al, 2007 Obesityassociated improvements in metabolic profile through expansion of adipose tissue J Clin Invest 117: 2621-2637.